Weighted Average Number of Shares Outstanding, Diluted of HCW Biologics Inc. from Q2 2021 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
HCW Biologics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2021 to Q3 2025.
- HCW Biologics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 2.26M shares, a 139% increase year-over-year.
- HCW Biologics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 38.8M shares, a 7.97% increase from 2023.
- HCW Biologics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 35.9M shares, a 0.3% increase from 2022.
- HCW Biologics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 35.8M shares, a 90.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)